No black box warning on record for Ciloxan

As of the latest FDA labeling reviewed, Ciloxan (CIPROFLOXACIN HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ciloxan medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS: FOR EYE USE ONLY NOT FOR INJECTION INTO THE EYE Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few pat

No black box warning on record for Ciloxan

Other warnings & precautions

WARNINGS: FOR EYE USE ONLY NOT FOR INJECTION INTO THE EYE Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few pat

Ciloxan Black Box Warning

No black box warning on record for Ciloxan

Other warnings & precautions

Ciloxan Black Box Warning

No black box warning on record for Ciloxan

Other warnings & precautions